CHAIR
Ron A. Andrews
Ron is a highly experienced and entrepreneurial Chair. Based in the USA, he is former President & CEO of Oncocyte, former member Board of Governors of ASCO’s CancerLinq program, and President, Genetic Sciences Division, Thermo Fisher Scientific. He has extensive corporate and investor contacts, having raised over $100m in growth capital.
CHIEF EXECUTIVE OFFICER
Professor Matthew J Baker
Inventor and leader in the field of clinical spectroscopy. Former Reader at University of Strathclyde. Top 6 KPMG Best British Tech Pioneers (2020), Fellowship of the Society for Applied Spectroscopy (2020), Top 40 under 40 Analytical Scientists (2018), RSC Harrison Meldola Prize (2017) and Emerging Leader in Molecular Spectroscopy (2016). Professor of Early Diagnostics, School of Medicine, University of Central Lancashire.
CHIEF SCIENTIFIC OFFICER
Professor David S Palmer
Over two decades of experience in the field of data analysis and machine learning. Computational chemist, leading the design and development of the Dxcover diagnostic algorithms. Reader in Chemistry at the University of Strathclyde.
CHIEF FINANCIAL OFFICER
John Duncan
A Chartered Accountant and leader in business financing through private equity and VC investments.
CHIEF TECHNICAL OFFICER
Dr Holly J Butler
A leader in the clinical spectroscopy field. Research Associate at University of Strathclyde and current MBA candidate. ‘Young Entrepreneur’ of the year winner, 2017 – Scottish Women’s Awards ‘Women in Innovation’ winner, 2017 – Global Game Changers Awards. Experienced researcher in biophotonics and infrared analysis.
GENERAL MANAGER
Dr David Eustace
Over a decade of experience in regulated diagnostic product development and medical device production in both start-up and multinational environments, most recently as Operations Director at Bruker Daltonics Microbiology and Diagnostics Division.
HEAD OF COMMERCIAL DEVELOPMENT (UK & EU)
Abigail Lishman
Career spanning two decades in international business development and commercial within the medical industry, with a strong focus on novel and paradigm-changing technologies in MedTech. Her role is to stimulate uptake of the Dxcover technology, including developing opportunities to grow and scale, with the ultimate aim of improving outcomes for patients, healthcare providers, and health systems.
HEAD OF HEALTH ECONOMIC & OUTCOMES RESEARCH
Dr Ewan Gray
Experienced health economist specialising in outcomes research. Independent consultant with previously experience in the development of diagnostic tests.